Related Experiment Video
Updated: Mar 7, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Cancer Incidence and Risk Factors in PLA2R-Associated Membranous Nephropathy
Ilario Russo1, Maria J Vargas-Brochero2, Anila Cara2
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, Bari, Italy.
Objective:
To evaluate cancer incidence, cancer types, and effect of immunosuppressive therapy and clinical parameters on cancer diagnosis in patients with phospholipase A2 receptor (PLA2R)-associated membranous nephropathy (MN).
Methods:
We conducted a retrospective cohort study of 239 adult patients with diagnosis of PLA2R-associated MN from January 1, 1996, to December 31, 2021. We assessed cancer incidence and explored the impact of immunosuppressive therapy, response to therapy, PLA2R antibody titers over time, and comorbidities in development of cancer.
Results:
Cancer incidence in our cohort was higher than expected on the basis of an age-adjusted US general population with a standardized incidence ratio of 1.93. Age, smoking habits, and previous history of cancer significantly increased risk for development of cancer after diagnosis of MN. Cyclophosphamide was also associated with an increased incidence of cancer, although not statistically significant. Other types of immunosuppressive therapy, PLA2R titers over time, and remission status were not associated with an increase in risk of cancer.
Conclusion:
The increased incidence of cancer in our cohort seems to be independent of PLA2R titers, remission status, or renal function. These findings suggest that traditional cancer risk factors-such as age, smoking, and prior malignant disease-do not fully explain the elevated malignancy risk, suggesting that PLA2R itself may contribute to oncogenesis through mechanisms not yet understood.
More Related Videos
10:59Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Related Concept Videos
Cancer Prevention
Some...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cytoskeletal Linker Proteins - Plakins
Abnormal Proliferation
Mechanisms of Retrovirus-induced Cancers
Induced Pluripotent Stem Cells
Somatic...